Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Net Asset Quality Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Net Asset Quality Index of 3.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.78 Billion minus total liabilities of $3.66 Billion yields net assets of $116.98 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see AMRX company net worth.
Quality Index
Net Assets
Total Assets
Total Liabilities
Amneal Pharmaceuticals, Inc. Class A Common Stock Net Asset Quality Index Over Time (2015–2025)
This chart shows how Amneal Pharmaceuticals, Inc. Class A Common Stock's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 3.1%, representing net assets of $116.98 Million against total assets of $3.78 Billion USD. See AMRX book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Amneal Pharmaceuticals, Inc. Class A Common Stock from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Amneal Pharmaceuticals, Inc. Class A Com to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 0.2% | $5.96 Million | $3.68 Billion | $3.67 Billion | ▲ +1.4 pp |
| 2024 | -1.3% | $-44.54 Million | $3.50 Billion | $3.55 Billion | ▼ -3.0 pp |
| 2023 | 1.8% | $61.30 Million | $3.47 Billion | $3.41 Billion | ▼ -3.7 pp |
| 2022 | 5.5% | $208.93 Million | $3.80 Billion | $3.59 Billion | ▼ -3.8 pp |
| 2021 | 9.3% | $366.97 Million | $3.94 Billion | $3.57 Billion | ▲ +0.4 pp |
| 2020 | 8.9% | $356.74 Million | $4.01 Billion | $3.65 Billion | ▼ -0.6 pp |
| 2019 | 9.5% | $346.79 Million | $3.67 Billion | $3.32 Billion | ▼ -11.1 pp |
| 2018 | 20.6% | $896.36 Million | $4.35 Billion | $3.46 Billion | ▲ +48.6 pp |
| 2017 | -28.0% | $-375.58 Million | $1.34 Billion | $1.72 Billion | ▼ -13.6 pp |
| 2016 | -14.4% | $-175.94 Million | $1.22 Billion | $1.39 Billion | ▲ +4.0 pp |
| 2015 | -18.4% | $-186.87 Million | $1.01 Billion | $1.20 Billion | — |